Disclosed are methods of preventing, treating, or diagnosing in a subject adisorder in protein folding or aggregation., or amyloid formation.,deposition, accumulation, or persistence consisting of administering to saidsubject a pharmaceutically effective amount of inositol stereoisomers,enantiomers or derivatives thereof.